IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 102 filers reported holding IRADIMED CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,369,692 | +26.0% | 53,407 | +35.6% | 0.00% | – |
| Q2 2023 | $1,880,552 | +92.2% | 39,391 | +58.4% | 0.00% | – |
| Q1 2023 | $978,380 | -3.6% | 24,863 | -30.7% | 0.00% | – |
| Q4 2022 | $1,015,441 | -16.6% | 35,894 | -11.4% | 0.00% | – |
| Q3 2022 | $1,217,000 | -27.7% | 40,491 | -18.4% | 0.00% | – |
| Q2 2022 | $1,683,000 | +81.6% | 49,598 | +140.1% | 0.00% | – |
| Q1 2022 | $927,000 | -30.8% | 20,659 | -28.7% | 0.00% | – |
| Q4 2021 | $1,339,000 | +181.9% | 28,989 | +104.8% | 0.00% | – |
| Q3 2021 | $475,000 | +24.7% | 14,152 | +9.1% | 0.00% | – |
| Q2 2021 | $381,000 | -54.6% | 12,969 | -60.2% | 0.00% | – |
| Q1 2021 | $840,000 | -37.9% | 32,602 | -45.1% | 0.00% | – |
| Q4 2020 | $1,352,000 | +205.9% | 59,338 | +187.1% | 0.00% | – |
| Q3 2020 | $442,000 | -44.6% | 20,668 | -40.0% | 0.00% | – |
| Q2 2020 | $798,000 | +8.1% | 34,419 | -0.5% | 0.00% | – |
| Q1 2020 | $738,000 | +114.5% | 34,588 | +135.1% | 0.00% | – |
| Q4 2019 | $344,000 | -41.5% | 14,713 | -47.4% | 0.00% | – |
| Q3 2019 | $588,000 | +119.4% | 27,949 | +113.1% | 0.00% | – |
| Q2 2019 | $268,000 | -16.8% | 13,118 | +14.3% | 0.00% | – |
| Q1 2019 | $322,000 | -28.6% | 11,481 | -37.8% | 0.00% | – |
| Q4 2018 | $451,000 | -53.4% | 18,448 | -29.1% | 0.00% | – |
| Q3 2018 | $967,000 | +83.1% | 26,027 | +2.3% | 0.00% | – |
| Q2 2018 | $528,000 | +84.0% | 25,432 | +27.4% | 0.00% | – |
| Q1 2018 | $287,000 | -20.7% | 19,969 | -16.6% | 0.00% | – |
| Q4 2017 | $362,000 | -5.5% | 23,936 | -40.1% | 0.00% | – |
| Q3 2017 | $383,000 | +55.1% | 39,976 | +39.2% | 0.00% | – |
| Q2 2017 | $247,000 | -76.5% | 28,728 | -75.7% | 0.00% | – |
| Q1 2017 | $1,050,000 | +29.6% | 118,004 | +61.9% | 0.00% | – |
| Q4 2016 | $810,000 | +153.9% | 72,890 | +287.4% | 0.00% | – |
| Q3 2016 | $319,000 | +6.7% | 18,814 | +37.0% | 0.00% | – |
| Q2 2016 | $299,000 | -24.7% | 13,732 | -33.7% | 0.00% | – |
| Q1 2016 | $397,000 | -5.0% | 20,716 | +38.9% | 0.00% | – |
| Q4 2015 | $418,000 | +134.8% | 14,915 | +104.2% | 0.00% | – |
| Q3 2015 | $178,000 | -75.1% | 7,303 | -76.3% | 0.00% | – |
| Q2 2015 | $716,000 | +1735.9% | 30,780 | +1099.5% | 0.00% | – |
| Q1 2015 | $39,000 | +225.0% | 2,566 | +179.5% | 0.00% | – |
| Q4 2014 | $12,000 | – | 918 | +5000.0% | 0.00% | – |
| Q3 2014 | $0 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |